PP_1170x120_10-25-21

omeprazole delayed-release capsules

Breckenridge set to release Prilosec generic

Breckenridge set to release Prilosec generic

BOCA RATON, Fla. — Breckenridge Pharmaceutical Inc. has earned Food and Drug Administration approval for omeprazole delayed-release capsules, an antacid, in 10-mg, 20-mg, 40-mg dosages. Breckenridge said its omeprazole product, AB-rated to AstraZeneca’s Prilosec, will be manufactured and supplied by its parent company, Laboratorios Dr. Esteve S.A., based in Barcelona, Spain. Launch plans are under

FDA gives OK to new Aurobindo generics

FDA gives OK to new Aurobindo generics

DAYTON, N.J. — Aurobindo Pharma Ltd. has received approval from the Food and Drug Administration for gemfibrozil tablets, omeprazole delayed-release capsules and telmisartan tablets. The company said Monday that its gemfibrozil tablets (600 mg) are a generic version of Lopid tablets from Pfizer Inc. The medication is indicated as an adjunctive therapy to diet for